Does the Beneficial Antipruritic Effect of Bezafibrate in Primary Biliary Cholangitis Depend on Autotaxin Activity?

Kremer A, Le Cleac'H A, Wolf K, Chazouilleres O, Lemoinne S, De Chaisemaitin L, Chollet-Martin S, Humbert L, Rainteauu D, Poupon R, Rousseau A, Corpechot C (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Hepatology Wiley-Blackwell

Book Volume: 68

Pages Range: 1083A-1083A

Authors with CRIS profile

Andreas Kremer Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Katharina Wolf Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Involved external institutions

Hôpital Saint-Antoine FR France (FR) Hôpital Bichat-Claude-Bernard (CHU, APHP) FR France (FR) University of Paris 4 - Paris-Sorbonne / Université paris IV Paris-Sorbonne FR France (FR)

How to cite

APA:

Kremer, A., Le Cleac'H, A., Wolf, K., Chazouilleres, O., Lemoinne, S., De Chaisemaitin, L.,... Corpechot, C. (2018). Does the Beneficial Antipruritic Effect of Bezafibrate in Primary Biliary Cholangitis Depend on Autotaxin Activity? (pp. 1083A-1083A).

MLA:

Kremer, Andreas, et al. "Does the Beneficial Antipruritic Effect of Bezafibrate in Primary Biliary Cholangitis Depend on Autotaxin Activity?" 2018. 1083A-1083A.

BibTeX: Download